Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.490 -0.040 (-2.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Geron Corporation - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Return On Capital Employed Overview: Geron
During Q1, Geron's (NASDAQ:GERN) reported sales totaled $137.00 thousand. Despite a 22.3% in earnings, the company posted a loss of $28.45 million. Geron collected $50.00 thousand... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers MediciNova (NASDAQ:MNOV) shares moved upwards by 50.79% to $5.67 during Monday's pre-market session. The market value of their outstanding shares is at $276.5... 
Via Benzinga
Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; CAI International Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 1.27% to 33,394.86 while the NASDAQ fell 0.92% to 14,031.05. The S&P also fell, dropping 1.03% to 4,178.31. The U.S. has... 
Via Benzinga
Topics Stocks
Earnings Scheduled For May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
58 Biggest Movers From Friday
Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Geron (NASDAQ:GERN) shares increased by 53.19% to $2.16 during Friday's regular session. As of 12:33 EST, Geron's stock is trading at a volume of 179.2... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises Over 1%; Orphazyme Shares Plunge
Midway through trading Friday, the Dow traded down 1.13% to 33,440.28 while the NASDAQ fell 0.74% to 14,056.31. The S&P also fell, dropping 0.92% to 4,183.07. The U.S. has the... 
Via Benzinga
Topics Stocks
32 Stocks Moving In Friday's Mid-Day Session
Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,... 
Via Benzinga
Why Geron Stock Is Soaring Today
Investors are cheering the company's encouraging phase 2 data. 
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) stock rose 21.47% to $5.26 during Friday's pre-market session. The company's market cap stands at $68.5 million.... 
Via Benzinga
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
28 Stocks Moving in Friday's Pre-Market Session
Gainers CAI International, Inc. (NYSE: CAI) rose 45.1% to $55.35 in pre-market trading after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Geron... 
Via Benzinga
Geron Stock Trading Is Higher On Reinforcing Imetelstat's Approach For Myelofibrosis Treatment, With Data Publication In Journal
Geron Corporation (NASDAQ: GERN) stock is trading higher during the premarket in reaction to data publication from the IMbark Phase 2 trial of imetelstat for... 
Via Benzinga
Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology
From Geron Corporation
Via Business Wire
Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress
From Geron Corporation
Via Business Wire
Geron: Return On Capital Employed Insights
During Q1, Geron's (NASDAQ:GERN) reported sales totaled $137.00 thousand. Despite a 22.3% in earnings, the company posted a loss of $28.45 million. In Q4, Geron brought in $50.00... 
Via Benzinga
Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress
From Geron Corporation
Via Business Wire
Geron (GERN) Q1 2021 Earnings Call Transcript
GERN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Geron: Q1 Earnings Insights
Shares of Geron (NASDAQ:GERN) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 12.50% over the past year to ($0.09),... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Vir Biotechnology (NASDAQ:VIR) sha... 
Via Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights
From Geron Corporation
Via Business Wire
Geron to Announce First Quarter 2021 Financial Results on May 10, 2021
From Geron Corporation
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 11.8% to $1.61 during Friday's pre-market session. The market value of their outstanding shares is at $205.... 
Via Benzinga
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 - Kehoe Law Firm, P.C. Investigation
Investigation To Determine Whether Certain Officers And/Or Directors Of Geron Corporation Breached Their Fiduciary Duties 
Via EIN Presswire
Topics Fraud
Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis
From Geron Corporation
Via Business Wire
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.